Today, UnitedHealth Group Inc. (UNH) to Issue Quarterly Dividend of $0.63 on December 13th

Today, UnitedHealth Group Inc. (UNH) to Issue Quarterly Dividend of $0.63 on  December 13th

UnitedHealth Group Inc. (NYSE:UNH) announced a quarterly dividend on Wednesday, November 9th. Shareholders of record on Friday, December 2nd will be paid a dividend of 0.625 per share by the healthcare conglomerate on Tuesday, December 13th. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date is Wednesday, November 30th.

Shares of UnitedHealth Group (NYSE:UNH) opened at 152.11 on Tuesday. The firm has a 50-day moving average price of $143.81 and a 200-day moving average price of $139.88. UnitedHealth Group has a 12 month low of $107.51 and a 12 month high of $154.50. The stock has a market cap of $144.61 billion, a price-to-earnings ratio of 25.31 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The company earned $46.30 billion during the quarter, compared to analysts’ expectations of $46.09 billion. During the same period last year, the company posted $1.77 earnings per share. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group will post $8.01 EPS for the current fiscal year.

A number of research analysts have issued reports on UNH shares. Credit Suisse Group AG reaffirmed an “outperform” rating and issued a $160.00 target price (up from $155.00) on shares of UnitedHealth Group in a report on Friday, October 21st. Mizuho cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating in a report on Wednesday, November 9th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $178.00 price target on shares of UnitedHealth Group in a research report on Tuesday, September 6th. Vetr lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 price target on the stock. in a research report on Tuesday, October 18th. Finally, Evercore ISI started coverage on shares of UnitedHealth Group in a research report on Thursday, September 22nd. They issued a “buy” rating and a $155.00 price target on the stock. Two research analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $158.03.

In other news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,460 shares of the firm’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $150.55, for a total transaction of $822,003.00. Following the completion of the transaction, the director now directly owns 60,052 shares in the company, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. 1.65% of the stock is currently owned by insiders.

Institutional investors have recently modified their holdings of the stock. American Century Companies Inc. increased its position in shares of UnitedHealth Group by 3.7% in the second quarter. American Century Companies Inc. now owns 2,624,148 shares of the healthcare conglomerate’s stock worth $370,530,000 after buying an additional 93,633 shares in the last quarter. Globeflex Capital L P increased its stake in UnitedHealth Group by 11.3% in the second quarter. Globeflex Capital L P now owns 3,919 shares of the healthcare conglomerate’s stock valued at $553,000 after buying an additional 397 shares during the period. Catalyst Capital Advisors LLC increased its stake in UnitedHealth Group by 4.0% in the second quarter. Catalyst Capital Advisors LLC now owns 5,250 shares of the healthcare conglomerate’s stock valued at $741,000 after buying an additional 200 shares during the period. Freestone Capital Holdings LLC increased its stake in UnitedHealth Group by 12.1% in the second quarter. Freestone Capital Holdings LLC now owns 1,941 shares of the healthcare conglomerate’s stock valued at $274,000 after buying an additional 209 shares during the period. Finally, NorthRock Partners LLC increased its stake in UnitedHealth Group by 39.6% in the second quarter. NorthRock Partners LLC now owns 4,287 shares of the healthcare conglomerate’s stock valued at $605,000 after buying an additional 1,217 shares during the period. 84.92% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

Related posts

Leave a Comment